General Information of the Compound
| Compound ID |
CP0269263
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[4-(3-Dibenzo[b,f]azepin-5-yl-propyl)-piperazin-1-yl]-ethanol
Show/Hide
|
||||||||||||||||||
| Synonyms |
G 33 040
Opipramol
Opipramol dihydrochloride
Opipramol hydrochloride
Opipramoli hydrochloridum
Opipramolo
Opipramolum
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H29N3O
|
||||||||||||||||||
| Molecular Weight |
363.505
|
||||||||||||||||||
| Canonical SMILES |
OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc23)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H29N3O/c27-19-18-25-16-14-24(15-17-25)12-5-13-26-22-8-3-1-6-20(22)10-11-21-7-2-4-9-23(21)26/h1-4,6-11,27H,5,12-19H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
YNZFUWZUGRBMHL-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
315-72-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound